Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

5.92

-0.07 (-1.17%)

At close: Jul 28, 2026, 4:00 PM EDT

5.92

0.00 (0.00%)

After-hours: Jul 28, 2026, 4:10 PM EDT

Harvard Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	27	299	930	2,322	1,140	2,901
Market Cap Growth	6.80%	-67.84%	-59.94%	103.71%	-60.71%	71.57%
Enterprise Value	64.04	333.22	969.2	2,359	1,189	2,950
Last Close Price	5.92	6.69	21.10	53.50	27.70	70.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	7.87	17.58	23.26	17.87	22.03
PEG Ratio	-	1.03	1.03	1.03	1.03	1.03
PS Ratio	0.32	3.46	9.88	20.68	10.06	24.39
PB Ratio	2.69	21.78	14.68	31.77	15.78	34.78
P/FCF Ratio	14.14	54.67	-	189.68	-	43292.10
P/OCF Ratio	8.77	44.45	645.81	165.50	989.28	2298.39

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.75	3.85	10.30	21.01	10.49	24.81
EV/EBITDA Ratio	11.53	-	1024.52	265.26	1852.63	304.50
EV/EBIT Ratio	-	-	-	1245.36	-	1427.74
EV/FCF Ratio	33.53	60.91	-	192.71	-	44025.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	4.24	3.11	0.10	0.49	0.67	0.62
Debt / EBITDA Ratio	7.67	-	45.81	4.65	84.49	5.88
Debt / FCF Ratio	22.29	7.81	-	3.38	-	850.15
Net Debt / Equity Ratio	3.53	2.49	0.62	0.51	0.69	0.59
Net Debt / EBITDA Ratio	6.39	-0.80	41.47	4.17	77.47	5.07
Net Debt / FCF Ratio	18.57	6.24	-32.58	3.03	-113.55	733.42
Asset Turnover	1.08	0.84	0.71	0.79	0.74	0.75
Inventory Turnover	1.65	1.66	1.64	1.81	1.94	2.06
Quick Ratio	0.91	1.12	0.35	0.77	0.91	1.17
Current Ratio	1.99	2.20	0.82	1.85	2.20	2.43
Return on Equity (ROE)	-139.92%	-169.98%	-26.18%	-10.83%	-15.12%	-3.12%
Return on Assets (ROA)	-0.11%	-46.51%	-4.91%	1.50%	-4.64%	1.38%
Return on Invested Capital (ROIC)	-0.18%	-63.91%	-6.09%	1.83%	-5.61%	1.70%
Return on Capital Employed (ROCE)	-0.15%	-74.86%	-6.81%	1.63%	-5.35%	1.52%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
FCF Yield	7.07%	1.83%	-	0.53%	-	0.00%
Buyback Yield / Dilution	-1.91%	-1.96%	-2.64%	-2.43%	-2.65%	-4.41%
Total Shareholder Return	-1.91%	-1.96%	-2.64%	-2.43%	-2.65%	-4.41%

SEC Filings: 10-K · 10-Q